This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1991 Jun 15;51(12):3075-9.

Mutator phenotype may be required for multistage carcinogenesis

L A Loeb¹

Affiliations

PMID: 2039987

Review

Mutator phenotype may be required for multistage carcinogenesis

L A Loeb. Cancer Res. 1991.

. 1991 Jun 15;51(12):3075-9.

Author

L A Loeb¹

Affiliation

¹ Joseph Gottstein Memorial Cancer Research Laboratory, Department of Pathology, University of Washington, School of Medicine, Seattle 98195.

PMID: 2039987

No abstract available

PubMed Disclaimer

Similar articles

A mutator phenotype in cancer.
Loeb LA. Loeb LA. Cancer Res. 2001 Apr 15;61(8):3230-9. Cancer Res. 2001. PMID: 11309271 Review.
Efficiency of carcinogenesis with and without a mutator mutation.
Beckman RA, Loeb LA. Beckman RA, et al. Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14140-5. doi: 10.1073/pnas.0606271103. Epub 2006 Sep 11. Proc Natl Acad Sci U S A. 2006. PMID: 16966602 Free PMC article.
Cancers exhibit a mutator phenotype: clinical implications.
Loeb LA, Bielas JH, Beckman RA. Loeb LA, et al. Cancer Res. 2008 May 15;68(10):3551-7; discussion 3557. doi: 10.1158/0008-5472.CAN-07-5835. Cancer Res. 2008. PMID: 18483233 Review.
Generation of mutator mutants during carcinogenesis.
Venkatesan RN, Bielas JH, Loeb LA. Venkatesan RN, et al. DNA Repair (Amst). 2006 Mar 7;5(3):294-302. doi: 10.1016/j.dnarep.2005.10.012. Epub 2005 Dec 15. DNA Repair (Amst). 2006. PMID: 16359931 Review.
Initial cellular targets and eventual genomic changes in multistage carcinogenesis.
Weinstein IB, Gattoni-Celli S, Kirschmeier P, Lambert M, Hsiao W, Backer J, Jeffrey A. Weinstein IB, et al. IARC Sci Publ. 1984;(56):277-97. IARC Sci Publ. 1984. PMID: 6549538 No abstract available.

See all similar articles

Cited by

ATPase activity of Plasmodium falciparum MLH is inhibited by DNA-interacting ligands and dsRNAs of MLH along with UvrD curtail malaria parasite growth.
Tarique M, Chauhan M, Tuteja R. Tarique M, et al. Protoplasma. 2017 May;254(3):1295-1305. doi: 10.1007/s00709-016-1021-8. Epub 2016 Sep 14. Protoplasma. 2017. PMID: 27624787
Multilevel modeling and value of information in clinical trial decision support.
Cui Y, Murphy B, Gentilcore A, Sharma Y, Minasian LM, Kramer BS, Coates PM, Gohagan JK, Klenk J, Tidor B. Cui Y, et al. BMC Syst Biol. 2014 Dec 24;8:6. doi: 10.1186/s12918-014-0140-0. BMC Syst Biol. 2014. PMID: 25540094 Free PMC article.
Early events during neoplastic progression in Barrett's esophagus.
Reid BJ. Reid BJ. Cancer Biomark. 2010;9(1-6):307-24. doi: 10.3233/CBM-2011-0162. Cancer Biomark. 2010. PMID: 22112482 Free PMC article. Review.
Pools and Pols: Mechanism of a mutator phenotype.
Sohl CD, Ray S, Sweasy JB. Sohl CD, et al. Proc Natl Acad Sci U S A. 2015 May 12;112(19):5864-5. doi: 10.1073/pnas.1505169112. Epub 2015 Apr 30. Proc Natl Acad Sci U S A. 2015. PMID: 25931524 Free PMC article. No abstract available.
The PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks.
Demény MA, Virág L. Demény MA, et al. Cancers (Basel). 2021 Apr 23;13(9):2042. doi: 10.3390/cancers13092042. Cancers (Basel). 2021. PMID: 33922595 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

CA 39903/CA/NCI NIH HHS/United States

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database